-
Je něco špatně v tomto záznamu ?
Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction
P. Wohlfahrt, J. Nativi-Nicolau, M. Zhang, CH. Selzman, T. Greene, J. Conte, JE. Biber, R. Hess, FL. Mondesir, O. Wever-Pinzon, SG. Drakos, EM. Gilbert, L. Kemeyou, B. LaSalle, BA. Steinberg, RU. Shah, JC. Fang, JA. Spertus, J. Stehlik
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
K08 HL136850
NHLBI NIH HHS - United States
K23 HL143156
NHLBI NIH HHS - United States
K23 HL150322
NHLBI NIH HHS - United States
UL1 TR002538
NCATS NIH HHS - United States
- MeSH
- dospělí MeSH
- dysfunkce levé srdeční komory patofyziologie MeSH
- hodnocení výsledků péče pacientem MeSH
- kohortové studie MeSH
- kvalita života * MeSH
- lidé středního věku MeSH
- lidé MeSH
- obnova funkce fyziologie MeSH
- prospektivní studie MeSH
- senioři MeSH
- srdeční selhání patofyziologie MeSH
- tepový objem * MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
Importance: Heart failure with recovered ejection fraction (HFrecEF) is a recently recognized phenotype of patients with a history of reduced left ventricular ejection fraction (LVEF) that has subsequently normalized. It is unknown whether such LVEF improvement is associated with improvements in health status. Objective: To examine changes in health-related quality of life in patients with heart failure with reduced ejection fraction (HFrEF) whose LVEF normalized, compared with those whose LVEF remains reduced and those with HF with preserved EF (HFpEF). Design, Setting, and Participants: This prospective cohort study was conducted at a tertiary care hospital from November 2016 to December 2018. Consecutive patients seen in a heart failure clinic who completed patient-reported outcome assessments were included. Clinical data were abstracted from the electronic health record. Data analysis was completed from February to December 2020. Main Outcomes and Measures: Changes in Kansas City Cardiomyopathy Questionnaire overall summary score, Visual Analog Scale score, and Patient-Reported Outcomes Measurement Information System domain scores on physical function, fatigue, depression, and satisfaction with social roles over 1-year follow-up. Results: The study group included 319 patients (mean [SD] age, 60.4 [15.5] years; 120 women [37.6%]). At baseline, 212 patients (66.5%) had HFrEF and 107 (33.5%) had HFpEF. At a median follow-up of 366 (interquartile range, 310-421) days, LVEF had increased to 50% or more in 35 patients with HFrEF (16.5%). Recovery of systolic function was associated with heart failure-associated quality-of-life improvement, such that for each 10% increase in LVEF, the Kansas City Cardiomyopathy Questionnaire score improved by an mean (SD) of 4.8 (1.6) points (P = .003). Recovery of LVEF was also associated with improvement of physical function, satisfaction with social roles, and a reduction in fatigue. Conclusions and Relevance: Among patients with HFrEF in this study, normalization of left ventricular systolic function was associated with a significant improvement in health-related quality of life.
Division of Cardiovascular Medicine University of Utah Health Salt Lake City
Institute for Clinical and Experimental Medicine Prague Czech Republic
Now with Xcenda Warrensburg Missouri
Saint Luke's Mid America Heart Institute Kansas City Missouri
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22012324
- 003
- CZ-PrNML
- 005
- 20220506131401.0
- 007
- ta
- 008
- 220425s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1001/jamacardio.2021.0939 $2 doi
- 035 __
- $a (PubMed)33950162
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Wohlfahrt, Peter $u University of Utah School of Medicine, Salt Lake City $u Center for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer Hospital, Prague, Czech Republic $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 245 10
- $a Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction / $c P. Wohlfahrt, J. Nativi-Nicolau, M. Zhang, CH. Selzman, T. Greene, J. Conte, JE. Biber, R. Hess, FL. Mondesir, O. Wever-Pinzon, SG. Drakos, EM. Gilbert, L. Kemeyou, B. LaSalle, BA. Steinberg, RU. Shah, JC. Fang, JA. Spertus, J. Stehlik
- 520 9_
- $a Importance: Heart failure with recovered ejection fraction (HFrecEF) is a recently recognized phenotype of patients with a history of reduced left ventricular ejection fraction (LVEF) that has subsequently normalized. It is unknown whether such LVEF improvement is associated with improvements in health status. Objective: To examine changes in health-related quality of life in patients with heart failure with reduced ejection fraction (HFrEF) whose LVEF normalized, compared with those whose LVEF remains reduced and those with HF with preserved EF (HFpEF). Design, Setting, and Participants: This prospective cohort study was conducted at a tertiary care hospital from November 2016 to December 2018. Consecutive patients seen in a heart failure clinic who completed patient-reported outcome assessments were included. Clinical data were abstracted from the electronic health record. Data analysis was completed from February to December 2020. Main Outcomes and Measures: Changes in Kansas City Cardiomyopathy Questionnaire overall summary score, Visual Analog Scale score, and Patient-Reported Outcomes Measurement Information System domain scores on physical function, fatigue, depression, and satisfaction with social roles over 1-year follow-up. Results: The study group included 319 patients (mean [SD] age, 60.4 [15.5] years; 120 women [37.6%]). At baseline, 212 patients (66.5%) had HFrEF and 107 (33.5%) had HFpEF. At a median follow-up of 366 (interquartile range, 310-421) days, LVEF had increased to 50% or more in 35 patients with HFrEF (16.5%). Recovery of systolic function was associated with heart failure-associated quality-of-life improvement, such that for each 10% increase in LVEF, the Kansas City Cardiomyopathy Questionnaire score improved by an mean (SD) of 4.8 (1.6) points (P = .003). Recovery of LVEF was also associated with improvement of physical function, satisfaction with social roles, and a reduction in fatigue. Conclusions and Relevance: Among patients with HFrEF in this study, normalization of left ventricular systolic function was associated with a significant improvement in health-related quality of life.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a srdeční selhání $x patofyziologie $7 D006333
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a hodnocení výsledků péče pacientem $7 D000071066
- 650 _2
- $a prospektivní studie $7 D011446
- 650 12
- $a kvalita života $7 D011788
- 650 _2
- $a obnova funkce $x fyziologie $7 D020127
- 650 12
- $a tepový objem $7 D013318
- 650 _2
- $a dysfunkce levé srdeční komory $x patofyziologie $7 D018487
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Nativi-Nicolau, Jose $u University of Utah School of Medicine, Salt Lake City
- 700 1_
- $a Zhang, Mingyuan $u University of Utah School of Medicine, Salt Lake City
- 700 1_
- $a Selzman, Craig H $u University of Utah School of Medicine, Salt Lake City
- 700 1_
- $a Greene, Thomas $u University of Utah School of Medicine, Salt Lake City
- 700 1_
- $a Conte, Jorge $u University of Utah School of Medicine, Salt Lake City
- 700 1_
- $a Biber, Joshua E $u University of Utah School of Medicine, Salt Lake City $u Now with Xcenda, Warrensburg, Missouri
- 700 1_
- $a Hess, Rachel $u University of Utah School of Medicine, Salt Lake City
- 700 1_
- $a Mondesir, Favel L $u University of Utah School of Medicine, Salt Lake City
- 700 1_
- $a Wever-Pinzon, Omar $u University of Utah School of Medicine, Salt Lake City
- 700 1_
- $a Drakos, Stavros G $u University of Utah School of Medicine, Salt Lake City
- 700 1_
- $a Gilbert, Edward M $u University of Utah School of Medicine, Salt Lake City
- 700 1_
- $a Kemeyou, Line $u University of Utah School of Medicine, Salt Lake City
- 700 1_
- $a LaSalle, Bernie $u University of Utah School of Medicine, Salt Lake City
- 700 1_
- $a Steinberg, Benjamin A $u University of Utah School of Medicine, Salt Lake City
- 700 1_
- $a Shah, Rashmee U $u University of Utah School of Medicine, Salt Lake City
- 700 1_
- $a Fang, James C $u University of Utah School of Medicine, Salt Lake City
- 700 1_
- $a Spertus, John A $u Saint Luke's Mid America Heart Institute, Kansas City, Missouri
- 700 1_
- $a Stehlik, Josef $u University of Utah School of Medicine, Salt Lake City $u Division of Cardiovascular Medicine, University of Utah Health, Salt Lake City
- 773 0_
- $w MED00191356 $t JAMA cardiology $x 2380-6591 $g Roč. 6, č. 8 (2021), s. 957-962
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33950162 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506131353 $b ABA008
- 999 __
- $a ok $b bmc $g 1789771 $s 1163525
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 6 $c 8 $d 957-962 $e 20210801 $i 2380-6591 $m JAMA cardiology $n JAMA Cardiol $x MED00191356
- GRA __
- $a K08 HL136850 $p NHLBI NIH HHS $2 United States
- GRA __
- $a K23 HL143156 $p NHLBI NIH HHS $2 United States
- GRA __
- $a K23 HL150322 $p NHLBI NIH HHS $2 United States
- GRA __
- $a UL1 TR002538 $p NCATS NIH HHS $2 United States
- LZP __
- $a Pubmed-20220425